載入...
Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?
P-glycoprotein (P-gp) is a key player in the multidrug-resistant phenotype in cancer. The protein confers resistance by mediating the ATP-dependent efflux of an astonishing array of anticancer drugs. Its broad specificity has been the subject of numerous attempts to inhibit the protein and restore t...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The American Society for Pharmacology and Experimental Therapeutics
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3965902/ https://ncbi.nlm.nih.gov/pubmed/24492893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.113.056176 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|